- Home
- MUR vs ACLX Comparison
MUR vs ACLX Comparison
Compare MUR & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$64.42
Company Overview
Basic Information| Metric | MUR | ACLX |
|---|---|---|
| Founded | 1950 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.7B |
| IPO Year | 1994 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MUR | ACLX |
|---|---|---|
| Price | $33.69 | $64.42 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 16 | 9 |
| Target Price | $29.00 | ★ $113.75 |
| AVG Volume (30 Days) | ★ 2.4M | 658.8K |
| Earning Date | 04-26-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $3,028,474,000.00 | $107,936,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.67 | $286.72 |
| P/E Ratio | $52.70 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $18.95 | $47.86 |
| 52 Week High | $35.19 | $94.07 |
Technical Indicators
Market Signals| Indicator | MUR | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 55.97 | 43.77 |
| Support Level | $31.40 | $66.12 |
| Resistance Level | $34.58 | $71.23 |
| Average True Range (ATR) | 1.36 | 2.67 |
| MACD | 0.21 | -0.17 |
| Stochastic Oscillator | 85.28 | 7.28 |
Price Performance
Historical Comparison MUR
ACLX
About MUR Murphy Oil Corporation
Murphy Oil Corp is an oil and gas exploration and production company, with both onshore and offshore operations and properties. It operates in two geographic reportable segments the United States and Canada. It generates the majority of its revenue form the United States.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.